Please assess the completion status of the following clinical trial:

Trial Title: A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients, 18-75 years of age;~* type 2 diabetes mellitus, with stable metformin treatment for \>=3 months;~* stable weight +/-10% for \>=3 months before screening.~Exclusion Criteria:~* type 1 diabetes mellitus;~* treatment with any anti-hyperglycemic medication other than metformin monotherapy during last 3 months;~* use of weight-lowering medications in the last 3 months;~* uncontrolled hypertension.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: EXPERIMENTAL): None
- 4 (Type: EXPERIMENTAL): None
- 5 (Type: EXPERIMENTAL): None
- 6 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).